Considerations for Defining Cytokine Dose, Duration, and Milieu That Are Appropriate for Modeling Chronic Low-Grade Inflammation in Type 2 Diabetes (Q28073309)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Considerations for Defining Cytokine Dose, Duration, and Milieu That Are Appropriate for Modeling Chronic Low-Grade Inflammation in Type 2 Diabetes |
scientific article |
Statements
14 references
13 March 2019
14 March 2019
10 references
13 references
13 March 2019
14 March 2019
23 October 2016
14 references
13 March 2019
14 March 2019
19 March 2019
24 March 2019
5 August 2019
20 August 2019
7 October 2019
10 October 2019
11 October 2019
12 October 2019
18 October 2019
20 November 2019
12 September 2020
4 February 2021
15 references
13 March 2019
14 March 2019
19 March 2019
24 March 2019
5 August 2019
20 August 2019
7 October 2019
10 October 2019
11 October 2019
12 October 2019
18 October 2019
20 November 2019
12 September 2020
4 February 2021
14 references
13 March 2019
14 March 2019
19 March 2019
24 March 2019
5 August 2019
20 August 2019
7 October 2019
10 October 2019
11 October 2019
12 October 2019
18 October 2019
20 November 2019
12 September 2020
4 February 2021
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference